Unresolved
We still don’t know whether anyone at this organisation has actually used this technology — zero lived-experience observations exist.
Not yet answered
What are we missing?
HealthAratus Intelligence
RapidAI
RapidAIRapidAI Intelligence
What the accumulated evidence, deployment record and lived experience actually show.
Intelligence lenses
Four ways of interrogating the same reality. Each changes the question, not the subject.
Do published findings about RapidAI match what happens in practice?
Still openWhether the reported magnitude holds in practice, and in which specialties it does not.
Public evidence
Plazza raises $15M from Accel, Elevation, Nexus to expand rapid medicine delivery - YourStory.com
HealthAratus Startup Scan via YourStory.com
Public evidence
A Multicenter, Prospective Study on the Diagnostic Efficacy of Femtosecond Laser Label-Free Imaging Combined With Artificial Intelligence-Assisted Diagnosis for Rapid Diagnosis of Lung Cancer Surgical Specimens
ClinicalTrials.gov AI
Public evidence
XiFin Names Chris Martin Chief Product Officer Amid Rapid AI-Enabled Empower Platform Growth
HIT Consultant
Public evidence
The Use of Artificial Intelligence-Enhanced Electrocardiograms in the Chest Pain Clinic to Risk Stratify Patients, Provide Rapid Reassurance and Enable a Low-Cost Clinical Pathway
ClinicalTrials.gov AI
Public evidence
How One Nigerian State Is Taking On Malaria
Forbes Healthcare
What we know · what we don’t
Everything here is open to being corrected by someone who has seen it first-hand.
What we still don’t know
Nobody has answered these yet. Your experience can help us understand what is happening.
Matters of record
Settled elsewhere. Context for reading the above, not something practice can confirm.
- 21 public external signal(s) across 10 source(s).Recorded by HealthAratus
Tool intelligence
What HealthAratus understands
HealthAratus currently understands RapidAI through company records and external market activity.
- Category
- imaging_diagnostics
What HealthAratus is still learning
HealthAratus is beginning to understand RapidAI. As evidence and experience accumulate, what remains unclear will be stated here.
Evidence & claims
What this is built on
The material the questions above were built from, with its attribution.
PathAI is a digital pathology platform that uses deep learning to analyze tissue slides. It assists pathologists with cancer detection, grading, and biomarker quantification.According to RapidAI
What RapidAI states
The vendor’s own claims. Testable where practice can actually test them.
Stated capability
The AI assists in quantifying biomarker expression, such as PD-L1 and HER2, on digitized pathology slides.
According to RapidAI
Does this change your workflow?
Independent and public evidence
Found in public sources. Not a clinician’s experience, and never presented as one.
Reported deployment
XiFin Names Chris Martin Chief Product Officer Amid Rapid AI-Enabled Empower Platform Growth
According to HIT Consultant
How widely is this actually used?
Reported deployment
How One Nigerian State Is Taking On Malaria
According to Forbes Healthcare
How widely is this actually used?
Reported deployment
The Use of Artificial Intelligence-Enhanced Electrocardiograms in the Chest Pain Clinic to Risk Stratify Patients, Provide Rapid Reassurance and Enable a Low-Cost Clinical Pathway
According to ClinicalTrials.gov AI
How widely is this actually used?
Reported outcome
A Multicenter, Prospective Study on the Diagnostic Efficacy of Femtosecond Laser Label-Free Imaging Combined With Artificial Intelligence-Assisted Diagnosis for Rapid Diagnosis of Lung Cancer Surgical Specimens
According to ClinicalTrials.gov AI
Are you seeing this result?
Recent change
Plazza raises $15M from Accel, Elevation, Nexus to expand rapid medicine delivery - YourStory.com
According to HealthAratus Startup Scan via YourStory.com
Have you noticed this shift?
Company participation
Not yet verified
A record of the reality forming around this technology already exists. No representative of the company has verified participation yet.
Claim your company profileReference
The stable facts, for interpreting everything above.
Overview
What it does
PathAI is a leading AI-powered pathology platform that transforms how tissue samples are analyzed for cancer diagnosis, drug development, and clinical research. The company's technology applies deep learning to digitized pathology slides, providing quantitative analysis of tissue morphology, biomarker expression, and…
Vendor & external product information, not independently verified by HealthAratus
Where it's used
Deployed in mixed settings
How the reality here has changed
Earlier activity concentrated on adoption state, workflow friction, accuracy quality. More recent activity concentrates on adoption state, accuracy quality.
Earlier
- adoption state
- workflow friction
- accuracy quality
More recently
- adoption state
- accuracy quality
Connected intelligence
Category intelligence